Business Today
Loading...

'Congratulations India!', PM Modi lauds approval of Serum Institute, Bharat Biotech's COVID-19 vaccines

PM Modi thanked doctors, medical staff, police personnel, sanitation workers and all corona warriors for their hard work during the coronavirus outbreak

twitter-logoBusinessToday.In | January 3, 2021 | Updated 12:32 IST
'Congratulations India!', PM Modi lauds approval of Serum Institute, Bharat Biotech's COVID-19 vaccines
AstraZeneca-Oxford University's Covishield vaccine and Bharat Biotech's Covaxin get approval for immunisation against Covid-19 in India

Hailing the approval of two "Made in India" coronavirus vaccines, Prime Minister Narendra Modi congratulated the country's scientists, innovators, and countrymen.

The PM wrote, "It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India!". He said the rapid manufacturing of the vaccines in the country is proof of the eagerness of scientists to fulfil the dream of Atmanirbhar Bharat.


The prime minister also wrote, "A decisive turning point to strengthen a spirited fight! DCGI granting approval to vaccines of Serum Institute of India and Bharat Biotech accelerates the road to a healthier and COVID-free nation. Congratulations India. Congratulations to our hardworking scientists and innovators".

PM Modi thanked doctors, medical staff, police personnel, sanitation workers and all corona warriors for their hard work during the coronavirus outbreak.

"We will remain eternally grateful to them for saving many lives," the Prime Minister said.

On Sunday, the Drugs Controller General of India (DCGI)  gave its official nod to AstraZeneca-Oxford University's Covishield vaccine and Bharat Biotech's  Covaxin for immunisation against Covid-19 in India.

The Serum Institute of India, the world's largest vaccine manufacturer, has tied up with Oxford-AstraZeneca to manufacture Covishield.

The approval by the DCGI was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

At this historic moment in India's medical history, SII Pune's CEO Adar Poonwalla also shared his happiness on Twitter. Poonwalla wrote, " Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks".

Also read: Serum Institute, Bharat Biotech vaccines get emergency use approval; first COVID-19 vaccines in India

Also read: Four variants of coronavirus found since beginning of pandemic, says WHO

  • Print
  • COMMENT
BT-Story-Page-B.gif
A    A   A
close